0001654954-23-015069.txt : 20231201 0001654954-23-015069.hdr.sgml : 20231201 20231201160137 ACCESSION NUMBER: 0001654954-23-015069 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231130 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20231201 DATE AS OF CHANGE: 20231201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENAX THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000034956 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262593535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34600 FILM NUMBER: 231459452 BUSINESS ADDRESS: STREET 1: 101 GLEN LENNOX DRIVE STREET 2: SUITE 300 CITY: CHAPEL HILL STATE: NC ZIP: 27517 BUSINESS PHONE: 919-855-2100 MAIL ADDRESS: STREET 1: 101 GLEN LENNOX DRIVE STREET 2: SUITE 300 CITY: CHAPEL HILL STATE: NC ZIP: 27517 FORMER COMPANY: FORMER CONFORMED NAME: OXYGEN BIOTHERAPEUTICS, INC. DATE OF NAME CHANGE: 20080703 FORMER COMPANY: FORMER CONFORMED NAME: SYNTHETIC BLOOD INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SINEQUANON CORP DATE OF NAME CHANGE: 19901219 8-K 1 tenx_8k.htm FORM 8-K tenx_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 30, 2023

 

TENAX THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

001-34600

26-2593535

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

101 Glen Lennox Drive, Suite 300

Chapel Hill, North Carolina 27517

(Address of principal executive offices) (Zip Code)

 

919-855-2100

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.0001 par value per share

TENX

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

 

Emerging growth company

☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.07

Submission of Matters to a Vote of Security Holders.

 

On November 30, 2023, Tenax Therapeutics, Inc. (the “Company”) convened the Company’s special meeting of stockholders (the “Special Meeting”). At the Special Meeting, stockholders voted on the proposal to approve an amendment to the Company’s certificate of incorporation, as amended, to authorize a reverse stock split of each issued and outstanding share of the Company’s common stock by a ratio of not less than one-for-ten (1:10) and not more than one-for-eighty (1:80), with the exact ratio to be determined by the Board in its sole discretion. The Board may implement or abandon this amendment no later than November 30, 2024.  The vote for this proposal was 6,198,812 shares for, 5,364,151 shares against, 23,186 shares abstaining, and no broker non-votes.

 

In addition, at the Special Meeting, stockholders approved the proposal regarding the adjournment of the Special Meeting, if necessary, to permit further solicitation and vote of proxies, if there are not sufficient votes at the time of the Special Meeting or any adjournment or postponement thereof to approve the proposal presented at the Special Meeting (the “Adjournment Proposal”). The Adjournment Proposal was approved at the Special Meeting, with a vote of 6,308,531 shares for, 5,052,193 shares against, 225,425 shares abstaining, and no broker non-votes. The Special Meeting was not adjourned.

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 1, 2023

Tenax Therapeutics, Inc.

 

 

 

 

 

 

By:

/s/ Christopher T. Giordano 

 

 

 

Christopher T. Giordano

 

 

 

President and Chief Executive Officer

 

 

 

3

 

 EX-101.SCH 2 tenx-20231130.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 tenx-20231130_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer EX-101.CAL 4 tenx-20231130_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 5 tenx-20231130_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 6 tenx-20231130_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 30, 2023
Cover [Abstract]  
Entity Registrant Name TENAX THERAPEUTICS, INC.
Entity Central Index Key 0000034956
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Nov. 30, 2023
Entity File Number 001-34600
Entity Incorporation State Country Code DE
Entity Tax Identification Number 26-2593535
Entity Address Address Line 1 101 Glen Lennox Drive
Entity Address Address Line 2 Suite 300
Entity Address City Or Town Chapel Hill
Entity Address State Or Province NC
Entity Address Postal Zip Code 27517
City Area Code 919
Local Phone Number 855-2100
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol TENX
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
XML 8 tenx_8k_htm.xml IDEA: XBRL DOCUMENT 0000034956 2023-11-30 2023-11-30 iso4217:USD shares iso4217:USD shares 0000034956 false 8-K 2023-11-30 TENAX THERAPEUTICS, INC. DE 001-34600 26-2593535 101 Glen Lennox Drive Suite 300 Chapel Hill NC 27517 919 855-2100 false false false false Common Stock, $0.0001 par value per share TENX NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://tenx.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tenx-20231130.xsd tenx-20231130_cal.xml tenx-20231130_def.xml tenx-20231130_lab.xml tenx-20231130_pre.xml tenx_8k.htm http://xbrl.sec.gov/dei/2023 true true JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tenx_8k.htm": { "nsprefix": "tenx", "nsuri": "http://tenx.com/20231130", "dts": { "schema": { "local": [ "tenx-20231130.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "tenx-20231130_cal.xml" ] }, "definitionLink": { "local": [ "tenx-20231130_def.xml" ] }, "labelLink": { "local": [ "tenx-20231130_lab.xml" ] }, "presentationLink": { "local": [ "tenx-20231130_pre.xml" ] }, "inline": { "local": [ "tenx_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://tenx.com/role/Cover", "longName": "000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-11-30to2023-11-30", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "tenx_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-11-30to2023-11-30", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "tenx_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 2", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001654954-23-015069-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-23-015069-xbrl.zip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end